A MONOCLONAL ANTIBODY TO AMYLOID IN THE BRAINS OF PATIENTS WITH ALZHEIMER'S DISEASE
- 1 September 1986
- journal article
- research article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 12 (5), 441-445
- https://doi.org/10.1111/j.1365-2990.1986.tb00052.x
Abstract
A monoclonal antibody that reacts with the amyloid in senile plaques in the brains of patients with Alzheimer's disease, was produced. The antigen was the crude amyloid protein (DAM, Pras et al. 1968) from the spleen of a patient with primary amyloidosis. The antibody crossreacts with DAM, but does not stain the amyloid of primary amyloidosis in tissue sections. The presence of a common antigenic site or sites in both the amyloid of senile plaques and amyloid of primary amyloidosis which react with this antibody is postulated.Keywords
This publication has 6 references indexed in Scilit:
- Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.The EMBO Journal, 1985
- SENILE PLAQUE AMYLOID, PAIRED HELICAL FILAMENTS, AND CEREBROVASCULAR AMYLOID IN ALZHEIMER'S DISEASE ARE ALL DEPOSITS OF THE SAME PROTEINThe Lancet, 1985
- Evidence for Blood‐Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT)Annals of the New York Academy of Sciences, 1982
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968
- The characterization of soluble amyloid prepared in waterJCI Insight, 1968